Technology: Novo Nordisk Stock Falls, Sanofi Rises On Drug Delay

Started by MikeLigalig.com, February 18, 2013, 01:28:57 PM

Previous topic - Next topic

MikeLigalig.com

Novo Nordisk Stock Falls, Sanofi Rises On Drug Delay

Shares of Novo Nordisk (NVO) plummeted more than 13% and Sanofi (SNY) rose 2% in early trading Monday, a day after Novo announced that its challenger to one of Sanofi's leading diabetes drugs has hit a roadblock. The FDA said it won't approve Novo's long-acting insulin candidate degludec until it gets more data assessing the possible heart risks associated with the drug. This was a surprise since the FDA went beyond the recommendations that its

Source: Novo Nordisk Stock Falls, Sanofi Rises On Drug Delay
For God so loved the world, that he gave his only Son (Jesus Christ), that whoever believes in him should not perish but have eternal life. For God did not send his Son into the world to condemn the world, but in order that the world might be saved through him. Whoever believes in him is not condemned, but whoever does not believe is condemned already, because he has not believed in the name of the only Son of God. - John 3:16-18

● ● ● ●
MOST AFFORDABLE health insurance HMO in the Philippines. Learn more at https://kwik.insure/at/mligalig